SM15685

N/A

Report date: 2024/10/11 11:10:40
NME

Base Information

Drug NameSM15685
Drug Alias NameSM-15685
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDYRK kinase inhibitors
TargetsDYRK kinase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiosplice Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiosplice Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A